Aryx Therapeutics I
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. The company uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of original drugs. Its products in clinical development portfolio include Tecarfarin (ATI-5923), an oral anticoagulant, which is in Phase III clinical development for the tre… Read more
Aryx Therapeutics I (ARYX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2010: 0.523x
Based on the latest financial reports, Aryx Therapeutics I (ARYX) has a cash flow conversion efficiency ratio of 0.523x as of September 2010.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.05 Million) by net assets ($-7.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aryx Therapeutics I - Cash Flow Conversion Efficiency Trend (2005–2009)
This chart illustrates how Aryx Therapeutics I's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aryx Therapeutics I Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aryx Therapeutics I ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
U-Swirl Inc
PINK:SWRL
|
0.167x |
|
Harena Rare Earths Plc
LSE:HREE
|
0.210x |
|
GOLDEN CROSS RES
MU:GCL
|
N/A |
|
OBTALA RES (OB7.SG)
STU:OB7
|
N/A |
|
BARON OIL
BE:GHA
|
N/A |
|
DVN (HLDGS)
BE:DVH
|
N/A |
|
Eco-Safe Systems Usa
PINK:ESFS
|
-350.801x |
|
American Oriental Bioengineering Inc
PINK:AOBI
|
-0.060x |
Annual Cash Flow Conversion Efficiency for Aryx Therapeutics I (2005–2009)
The table below shows the annual cash flow conversion efficiency of Aryx Therapeutics I from 2005 to 2009.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2009-12-31 | $-2.92 Million | $-34.97 Million | 11.991x | +827.02% |
| 2008-12-31 | $27.41 Million | $-45.22 Million | -1.649x | -110.43% |
| 2007-12-31 | $35.35 Million | $-27.70 Million | -0.784x | -1843.45% |
| 2006-12-31 | $-93.71 Million | $-4.21 Million | 0.045x | -86.55% |
| 2005-12-31 | $-67.09 Million | $-22.43 Million | 0.334x | -- |